Cargando…

Impact of signal-averaged electrocardiography findings on appropriate shocks in prophylactic implantable cardioverter defibrillator patients with nonischemic systolic heart failure

BACKGROUND: Appropriate shock therapy is associated with subsequent all-cause death in heart failure (HF) patients who receive an implantable cardioverter defibrillator (ICD) for the primary prevention of sudden cardiac death. To evaluate the impact of signal-averaged electrocardiography (SAECG) fin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nomoto, Michiru, Suzuki, Atsushi, Shiga, Tsuyoshi, Shoda, Morio, Hagiwara, Nobuhisa
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382808/ https://www.ncbi.nlm.nih.gov/pubmed/35974317 http://dx.doi.org/10.1186/s12872-022-02811-6

Ejemplares similares

Left intraventricular pressure gradient in hypertrophic cardiomyopathy patients receiving implantable cardioverter-defibrillators for primary prevention
por: Yazaki, Kyoichiro, et al.
Publicado: (2021)

Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up
por: Gandhi, Kaushang, et al.
Publicado: (2010)

Deactivation of implantable cardioverter defibrillator in Japanese patients with end‐stage heart failure
por: Nakazawa, Mayui, et al.
Publicado: (2020)

Incidence and predictors of early and late sudden cardiac death in hospitalized Japanese patients with new‐onset systolic heart failure
por: Minami, Yoshiaki, et al.
Publicado: (2021)

Avoidance behavior associated with depressive symptoms in patients with implantable cardioverter defibrillators
por: Ichikura, Kanako, et al.
Publicado: (2017)

Implantable cardioverter defibrillator in nonischemic cardiomyopathy: A systematic review and meta‐analysis
por: Khan, Safi U., et al.
Publicado: (2017)

Response: Impact of implantable cardioverter defibrillator on survival in patients with nonischemic dilated cardiomyopathy
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

An appropriate shock of the wearable cardioverter-defibrillator in an outpatient setting
por: Kishihara, Jun, et al.
Publicado: (2016)

Subcutaneous Implantable Cardioverter-Defibrillator Shock: Appropriate or Inappropriate?
por: Ip, James E.
Publicado: (2017)

Transvenous shock‐only implantable cardioverter defibrillator after an atrio‐pulmonary Fontan surgery
por: Toyohara, Keiko, et al.
Publicado: (2020)

Overweight and obesity as protective factors against mortality in nonischemic cardiomyopathy patients with an implantable cardioverter defibrillator
por: Zhou, Bin, et al.
Publicado: (2020)

Mortality among ischemic and nonischemic heart failure patients with a primary implantable cardioverter‐defibrillator
por: Yang, Pil‐Sung, et al.
Publicado: (2021)

The impact of implantable cardioverter defibrillator on the prognosis of nonischemic dilated cardiomyopathy patients compared with standard medical treatments
por: Salehi Omran, Hossein, et al.
Publicado: (2023)

Transvenous Biopsy of a Primary Cardiac Lymphoma Guided by Real-Time 3-Dimensional Reconstructed Imaging From Intracardiac Echography
por: Nomoto, Michiru, et al.
Publicado: (2021)

Gender Differences in Appropriate Shocks and Mortality among Patients with Primary Prophylactic Implantable Cardioverter-Defibrillators: Systematic Review and Meta-Analysis
por: Conen, David, et al.
Publicado: (2016)

Late potentials on signal-averaged electrocardiography eliminated by successful catheter ablation of premature ventricular contractions in a nonischemic cardiomyopathy patient
por: Sugawara, Masafumi, et al.
Publicado: (2023)

Predictors of appropriate ICD therapy in patients with implantable cardioverter-defibrillator
por: Dehghani, Mohammad Reza, et al.
Publicado: (2006)

Left atrial reentrant tachycardia with interatrial dissociation mimicking accelerated idioventricular rhythm in a patient with a cardiac resynchronization defibrillator
por: Yazaki, Kyoichiro, et al.
Publicado: (2021)

Fragmented QRS as a Predictor of Appropriate Implantable Cardioverter-defibrillator Therapy
por: Apiyasawat, Sirin, et al.
Publicado: (2014)

Baseline and Dynamic Risk Predictors of Appropriate Implantable Cardioverter Defibrillator Therapy
por: Wu, Katherine C., et al.
Publicado: (2020)

Impact of Moderate to Severe Renal Impairment on Mortality and Appropriate Shocks in Patients with Implantable Cardioverter Defibrillators
por: Alla, Venkata M., et al.
Publicado: (2010)

Impact of fracture‐prone implantable cardioverter defibrillator leads on long‐term patient mortality
por: Koike, Toshiharu, et al.
Publicado: (2023)

An overlap of Brugada syndrome and arrhythmogenic right ventricular cardiomyopathy/dysplasia
por: Kataoka, Shohei, et al.
Publicado: (2016)

Association of Night-Time Heart Rate With Ventricular Tachyarrhythmias, Appropriate and Inappropriate Implantable Cardioverter-Defibrillator Shocks
por: Sun, Xuerong, et al.
Publicado: (2021)

Management of implantable cardioverter-defibrillator patients with appropriate ICD shocks: A 3-step treatment concept
por: Kleemann, Thomas, et al.
Publicado: (2021)

Appropriateness of Prescription and Safety of Wearable Cardioverter Defibrillators: A Single-center Experience
por: Sundhu, Murtaza, et al.
Publicado: (2019)

Appropriate therapy for implantable cardioverter defibrillators used as primary versus secondary prophylaxis
por: Thuraiaiyah, J, et al.
Publicado: (2023)

Age-stratified comparison of prognosis in cardiac resynchronization therapy with or without prophylactic defibrillator for nonischemic cardiomyopathy—a nationwide cohort study
por: Farouq, Maiwand, et al.
Publicado: (2023)

Implantable cardioverter-defibrillators /
Publicado: (1994)

Prognostic significance of diastolic dysfunction in patients with systolic dysfunction undergoing atrial fibrillation ablation
por: Koike, Toshiharu, et al.
Publicado: (2022)

Sex difference in appropriate shocks but not mortality during long-term follow-up in patients with implantable cardioverter-defibrillators
por: Seegers, Joachim, et al.
Publicado: (2016)

Optimal Medications and Appropriate Implantable Cardioverter-defibrillator Shocks in Aborted Sudden Cardiac Death Due to Coronary Spasm
por: Sueda, Shozo, et al.
Publicado: (2018)

QRS complex and T wave planarity for the prediction of death and appropriate shocks in recipients of prophylactic implantable defibrillators
por: Novotny, T, et al.
Publicado: (2023)

Prognostic Significance of Post-Procedural Left Ventricular Ejection Fraction Following Atrial Fibrillation Ablation in Patients With Systolic Dysfunction
por: Yazaki, Kyoichiro, et al.
Publicado: (2020)

Appropriate Implantable Cardioverter-Defibrillator Therapies Delivered 5 Years After End of Service
por: Yuyun, Matthew F., et al.
Publicado: (2020)

An “UninTENSional” Subcutaneous Implantable Cardioverter-defibrillator Shock
por: Turner, Suzette L., et al.
Publicado: (2018)

Phantom Shocks Associated With a Wearable Cardioverter Defibrillator
por: Delle Donna, Paul, et al.
Publicado: (2021)

Inappropriate subcutaneous implantable cardioverter-defibrillator shocks for bradycardia
por: Chua, Kelvin C.M., et al.
Publicado: (2021)

Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator
por: van Barreveld, M., et al.
Publicado: (2017)

Mortality and predictors of appropriate implantable cardioverter defibrillator therapy in Japanese patients with Multicenter Automatic Defibrillator Implantation Trial II criteria
por: An, Yoshimori, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_l440jcqkhenjdira3cos6qtl59